Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
GE HealthCare Technologies Inc.
Bear Case (25th pct.)
-9.3% vs price
Base Case (Median)
-2.7% vs price
Bull Case (75th pct.)
28.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $111.00 | 70.8% | High (40%) |
| PE Comparable | $97.70 | 50.3% | Medium (25%) |
| Growth Trajectory DCF | $63.24 | -2.7% | Medium (20%) |
| Graham Number | $47.35 | -27.1% | Medium (40%) |
| EV/EBITDA | $69.26 | 6.6% | Medium (20%) |
| EV/FCF | $55.42 | -14.7% | Medium (20%) |
| Earnings Power Value | $62.45 | -3.9% | Medium (50%) |
Based on 7 out of 7 methods, GEHC appears fairly valued at the current price of $64.99. The base case fair value of $63.24 implies 2.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.